Finding new treatments for syphilis.
SBIR Topic 134: Alternatives to Benzathine Penicillin for Treatment of Syphilis
This study is looking for new and better ways to treat syphilis, so patients can have more effective options with fewer side effects than the usual treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Chromologic, LLC NIH-funded |
| Lab location | 1 site (Monrovia, United States) |
| Project ID | NIH-11203271 on NIH RePORTER |
What this research studies
This research focuses on developing alternative therapeutics for the treatment of syphilis, a sexually transmitted infection. The project aims to identify and create new treatment options that could be more effective or have fewer side effects than the current standard, Benzathine Penicillin. By exploring innovative therapeutic agents, the research seeks to improve patient outcomes and address the growing need for effective syphilis treatments. Patients may be involved in trials or benefit from new therapies developed through this initiative.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with syphilis who may benefit from alternative treatment options.
Not a fit: Patients who have already been effectively treated with Benzathine Penicillin may not receive additional benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with more effective and safer treatment options for syphilis.
How similar studies have performed: While there have been various approaches to treating syphilis, this research aims to explore novel alternatives, making it a potentially innovative endeavor.
Where this research is happening
Monrovia, United States
- Chromologic, LLC — Monrovia, United States (Active)
Researchers
- Principal investigator: Jimenz, Jorge — Chromologic, LLC
- Study coordinator: Jimenz, Jorge
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.